↓ Skip to main content

PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications

Overview of attention for article published in Molecular Cancer, March 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#50 of 1,810)
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
3 news outlets
twitter
2 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
157 Dimensions

Readers on

mendeley
193 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Published in
Molecular Cancer, March 2020
DOI 10.1186/s12943-020-01167-9
Pubmed ID
Authors

Heng Zhu, Miaoyan Wei, Jin Xu, Jie Hua, Chen Liang, Qingcai Meng, Yiyin Zhang, Jiang Liu, Bo Zhang, Xianjun Yu, Si Shi

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 193 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 193 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 13%
Student > Ph. D. Student 23 12%
Researcher 20 10%
Student > Master 16 8%
Student > Doctoral Student 15 8%
Other 19 10%
Unknown 74 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 45 23%
Medicine and Dentistry 32 17%
Agricultural and Biological Sciences 10 5%
Chemistry 6 3%
Unspecified 5 3%
Other 17 9%
Unknown 78 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2023.
All research outputs
#1,115,140
of 24,122,534 outputs
Outputs from Molecular Cancer
#50
of 1,810 outputs
Outputs of similar age
#27,116
of 364,102 outputs
Outputs of similar age from Molecular Cancer
#1
of 41 outputs
Altmetric has tracked 24,122,534 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,810 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,102 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.